Revascularization reduces mortality in patients with high risk coronary artery disease based on multi-slice CT

Original title: All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Reference: James K Min et al. European Heart Journal (2012) 33, 3088–3097 doi:10.1093/eurheartj/ehs315.

Several large studies have shown revascularization reduces mortality in stable patients with high risk CAD based on conventional angiography. The goal of this study was to determine the impact in mortality rate of revascularization vs. medical therapy of patients with coronary disease based on CT. 

This observational study included 15223 patients without known coronary condition undergoing multi-slice coronary CT (≥ 64 detectors), divided in high risk (two-vessel CAD with proximal left anterior descending artery involvement, three-vessel CAD, and left main CAD) and low risk CAD. To identify revascularization or medical therapy predictors, they created a score developed by logistic regression. The primary end point was all-cause mortality. 

Revascularization rate was different depending on severity, from 3.8% for non-high-risk CAD to 51.2% high-risk CAD (p<0.01). 82.8% of revascularized patients were treated with angioplasty. Follow up median was 2.1 years (interquartile range 1.4-3.3 years).

After adjusting confounding factors, a reduction in all-cause mortality rates was observed in revascularized patients with high risk CAD, compared to those that received medical therapy (2.28% vs. 5.34% respectively p=0.0075). In low risk CAD patients no differences were observed (2.06% vs. 0.97% p=0.138).

Conclusion 

In patients with no previous history of CAD classified as high risk CAD patients based on multi-slice CT, revascularization reduced all-cause mortality rate.

Editorial Comment:

As an observation study, all outcomes produce more hypotheses that require further randomized studies. On the other hand, CTs are competing with functional studies as screening techniques and this study provides us with the tools to decide when to proceed with coronary angiography and revascularization.

SOLACI.ORG

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...